BLACK WEEKSInjektiopullot −15 % · kitit −10 % · muut −5 %koodillaIlmainen toimitus Saksaan alk. €200

Tämä sivu on käännetty automaattisesti, ja siinä voi olla virheitä. Onko suomi äidinkielesi? Otamme mielellämme vastaan palautetta ja korjauksia.Lähetä palautetta

The Peptide Desk The Peptide Desk
CagriSema (Cagri+Sema), tuotekuva

Laboratorioraportti

PDF
99%
Puhtaus
Testattu
CagriSema (Cagri+Sema) 10mg (5+5)
Laboratorio
Analiza Białek
Päivämäärä
October 2026
Tulos
99% purity (Cagrilintide 5.29 mg + Semaglutide 5.15 mg)
Endotoksiinit
5.73 EU/vial
Tilauksen nro
Salasana

Testattu riippumattomasti, tarkistettavissa salasanalla suoraan laboratoriossa.

GLP-1

CagriSema (Cagri+Sema)

GLP-1

Tilaus

Kappalehinta - Ilmainen toimitus Saksaan yli 200 €:n tilauksille Black Weeksin aikana
  • DHL seurannalla
  • Huomaamaton pakkaus

4.6/5 Trustpilotissa73 arvostelua

Yhdellä silmäyksellä

CagriSema (Cagri+Sema) lukuina

Tietopankkimme keskeiset luvut.

Koko tietopankkiartikkeli
Class
Amylin analog + GLP-1 agonist
Use
Subcutaneousweekly
Sizes
5 to 20 mg3 sizes in the shop

Tietoa

Kaikki aiheesta CagriSema (Cagri+Sema)

Tilaa samalla

Mitä tarvitset sen kanssa

Bakteriostaattinen vesi lisätään ostoskoriisi automaattisesti. Ruiskut ja pyyhkeet yhdellä napsautuksella.

Insuliiniruiskut

10 kpl · 5.50 €

Alkoholipyyhkeet

50 kpl · 10 €

Kuinka paljon vettä?

Ruiskun yksiköt injektiopullosi koolle.

Avaa laskuri →

FAQ

Usein kysyttyä

Lähteet jokaiseen vastaukseen: tietopankkiartikkeli

Onko sinulla vielä kysyttävää?

Kirjoita meille, tiimimme auttaa sinua.

Is CagriSema approved?

No, the combination is not approved (as of 26 October 2026). Semaglutide alone has been approved since 2017, ChEMBL lists cagrilintide with phase 3 as the highest phase. ClinicalTrials.gov lists 18 phase 3 trials of the combination, 10 of them completed.

What does the combination add over the single compounds?

In REDEFINE 1 the combination came out ahead after 68 weeks. For all participants: -20.4 percent versus -14.9 (semaglutide alone), -11.5 (cagrilintide alone) and -3.0 (placebo). When taken as planned: -22.7 versus -16.1, -11.8 and -2.3 percent. The values of the single compounds come from the manufacturer's announcement, the abstract only reports combination and placebo.

Why two compounds in one vial?

Because they act on different receptors. Cagrilintide binds to amylin and calcitonin receptors, semaglutide to the GLP-1 receptor. In rats cagrilintide worked through specific nerve cells in the brainstem that semaglutide did not need. The effects on satiety and the stomach thus add up.

What do the trials show in type 2 diabetes?

In REDEFINE 2 weight fell by 13.7 percent after 68 weeks (placebo 3.4), 73.5 percent reached an HbA1c of 6.5 percent or below (placebo 15.9). In phase 2 HbA1c fell by 2.2 percentage points in 32 weeks. In REIMAGINE 2 the combination was slightly but significantly ahead of semaglutide alone on HbA1c.

How long do the compounds stay in the body?

In the first study of the combination the half-life of cagrilintide was 159 to 195 hours, that of semaglutide 145 to 165 hours, so both about one week. Cagrilintide did not change semaglutide blood levels. That is why the trials give the combination once a week.

Which side effects were seen?

Mainly gastrointestinal effects such as nausea, vomiting, diarrhoea or constipation: in REDEFINE 1 in 79.6 percent (placebo 39.9), in REDEFINE 2 in 72.5 percent (placebo 34.4). According to the trials they were mostly mild to moderate and passed.

How did the combination do directly against semaglutide?

In REDEFINE 5 in Japan and Taiwan weight fell by 18.4 percent with the combination after 68 weeks, by 11.9 percent with semaglutide alone. Gastrointestinal effects were similarly common in both groups (53 versus 51 percent).

Liittyvät

Samankaltaiset tuotteet